game changing PoC screening device to be used at the front line in the fight against Corona.

冠状病毒的快速传播导致需要可靠的护理点(PoC)工具来提供对病毒的快速筛查。冠状病毒通过小水滴、气雾剂、咳嗽、打喷嚏或只是在呼出的呼气中释放来传播，并且有科学证据支持通过呼出的呼吸冷凝物(EBC)准确检测病毒。我们打算扩展现有的技术Inflammacheck(R)，以在EBC中测试冠状病毒。Inflammacheck(R)是一种手持、非侵入性的护理点(PoC)设备，它检测EBC中的过氧化氢(H2O2)，这是一种有充分证据证明的呼吸道系统炎症状况的生物标志物。包括样品采集和测试化验在内的整个测试周期通常在5分钟内完成，程序完全自动化。Inflammacheck(R)获得CE认证，并在MHRA注册，于2019年9月在英国和欧盟销售和使用。我们的目标是在Inflammacheck的框架内部署特定于电晕的传感器，以建立一种易于使用、快速和可靠的冠冕筛选设备。在通过可行性研究进行概念验证之后，我们打算与合适的合作伙伴合作，推动概念的扩大和商业化。为了缩短上市时间，我们打算启动规模扩大计划，额外的临床试验，以及在获得概念验证后立即进行的监管处理；也就是说，甚至在达成合作伙伴协议并就合作伙伴资金达成一致之前。

The rapid spread of the Corona virus leads to a need for reliable Point of Care (PoC) tools offering rapid screening for the virus.Corona spreads via small droplets, aerosols, being released in coughs, sneezes or simply in the exhaled breath, and scientific evidence exists to support the accurate detection of virus by Exhaled Breath Condensate (EBC).We intend to expand on an existing technology, the Inflammacheck(r), to test for Corona in EBC. The Inflammacheck(r) is a handheld, non-invasive, Point-of-Care (PoC) device which detects hydrogen peroxide (H2O2) in EBC, a well-documented biomarker for inflammatory conditions in the airways system. The full test cycle including sample collection and test assay typically takes place in 5 minutes following a fully automated procedure.The Inflammacheck(r) is CE marked and registered with the MHRA for sales and use in the UK as well as in the EU by September 2019\.We aim to deploy a Corona specific sensor within the framework of the Inflammacheck to establish an easy-to-use, rapid and reliable screening device for Corona.Following proof-of-concept through a feasibility study, we intend to partner up with a suitable partner to drive scale up and commercialisation of the concept.To reduce time to market, we intend to initiate planning for scale up, additional clinical trials, and regulatory handling immediately after having obtained proof-of-concept; that is, even before having a partner agreement in place and having agreed on partner funding.